Skip to content

Form 4 filed by Daewoong Co., Ltd

Daewoong Co., Ltd filed this Form 4 on AEON (AEON Biopharma, Inc.) with 3 transaction rows and 3 holding rows, accepted by EDGAR 2026-11-10 16:35:47 UTC.

Accession
0001213900-26-117865
Filed
2026-11-10
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Issuer and reporting owners

Issuer: AEON · AEON Biopharma, Inc. (CIK 1837607)

Rows

SecurityDateCodeSharesPriceOwned afterOwnership
Class A Common Stock, $0.0001 par value per share 2026-10-30X exercised+11,236,631$0.000123,188,345I By Daewoong Pharmaceutical Co., Ltd.
Class A Common Stock, $0.0001 par value per share 2026-10-30J other-3,822$0.29423,184,523I By Daewoong Pharmaceutical Co., Ltd.
Class A Common Stock, $0.0001 par value per share holding 58,023D
Pre-Funded Warrant (right to buy) derivative2026-10-30X exercised-11,236,631$00I By Daewoong Pharmaceutical Co., Ltd.
Common Stock Warrant (right to buy) derivativeholding 8,000,000I By Daewoong Pharmaceutical Co., Ltd.
Senior Secured Convertible Note derivativeholding I By Daewoong Pharmaceutical Co., Ltd.